We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Jan 20
BAVENCIO was approved by the US Food and Drug Administration (FDA), for the treatment of patients with locally…
19 Dec 19
BLISS-LN clinical trial evaluated the safety and efficacy of Benlysta in the enrolled 448 patients with active lupus…
19 Dec 19
TRIUMPH clinical trial is expected to enrol approximately 2,850 patients from multiple sites across the US, Europe and…
12 Dec 19
LOXO-292 is a highly selective and potent, oral investigational medicine, which is currently under clinical development for the…
The new drug differs from many established acute migraine treatments by lowering blood pressure, rather than raising it
18 Nov 19
Repatha reduces the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease
Japanese scientists first sourced halichondrin from sea sponges in 1986, and have been attempting to manufacture it for…
13 Nov 19
The EMPULSE study is a multi-centre, randomised, double-blind study to assess the oral EMPagliflozin 10mg compared to placebo
11 Nov 19
Gazyva is a monoclonal antibody designed to attach to CD20, a protein that can be observed only on…
08 Nov 19
INXN-4001 makes use of non-viral delivery of a constitutively expressed multigenic plasmid to express human S100A1, SDF-1α, and…